Stock HAE HAEMONETICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Haemonetics Corporation

Equities

HAE

US4050241003

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-18 pm EDT 		5-day change 1st Jan Change
83.46 USD -1.67% Intraday chart for Haemonetics Corporation -3.54% -2.40%
Apr. 04 Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge MT
Apr. 04 Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
PR
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge
AQ
Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge
MT
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
PR
Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge
CI
Haemonetics Corporation Completes Acquisition of Attune Medical
PR
Haemonetics Corporation completed the acquisition of Advanced Cooling Therapy, Inc.
CI
Haemonetics to Acquire Attune Medical for $160 Million
MT
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
PR
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
PR
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
PR
Haemonetics Q3 Adjusted Earnings, Revenue Increase; Shares Rise
MT
Transcript : Haemonetics Corporation, Q3 2024 Earnings Call, Feb 08, 2024
North American Morning Briefing : S&P 500 to Open -2-
DJ
Haemonetics: Fiscal Q3 Earnings Snapshot
AQ
Haemonetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023
CI
Haemonetics Corporation Updates Revenue Guidance for the Fiscal Year 2024
CI
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
PR
Transcript : Haemonetics Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 09:45 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HAE Stock
  4. News Haemonetics Corporation